Found: 6
Select item for more details and to access through your institution.
Low bone mineral density due to secondary hyperparathyroidism in the Gla<sup>tm</sup>Tg(CAG‐A4GALT) mouse model of Fabry disease.
- Published in:
- FASEB Bioadvances, 2020, v. 2, n. 6, p. 365, doi. 10.1096/fba.2019-00080
- By:
- Publication type:
- Article
On pandemics, pandemonium, and possibilities...
- Published in:
- FASEB Bioadvances, 2020, v. 2, n. 6, p. 329, doi. 10.1096/fba.2020-00023
- By:
- Publication type:
- Article
Depleting interferon regulatory factor‐1(IRF‐1) with CRISPR/Cas9 attenuates inducible oxidative metabolism without affecting RA‐induced differentiation in HL‐60 human AML cells.
- Published in:
- FASEB Bioadvances, 2020, v. 2, n. 6, p. 354, doi. 10.1096/fba.2020-00004
- By:
- Publication type:
- Article
A brief history of FASEB and its programs and activities.
- Published in:
- FASEB Bioadvances, 2020, v. 2, n. 6, p. 331, doi. 10.1096/fba.2020-00009
- By:
- Publication type:
- Article
LCRF‐0006, a small molecule mimetic of the N‐cadherin antagonist peptide ADH‐1, synergistically increases multiple myeloma response to bortezomib.
- Published in:
- FASEB Bioadvances, 2020, v. 2, n. 6, p. 339, doi. 10.1096/fba.2019-00073
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- FASEB Bioadvances, 2020, v. 2, n. 6, p. 325, doi. 10.1096/fba.1061
- Publication type:
- Article